INTERNATIONAL PATENT: SUZHOU TRANSCENTA THERAPEUTICS CO., LTD., TRANSCENTA HOLDING LIMITED, TRANSCENTA THERAPEUTICS, INC. FILES APPLICATION FOR "FORMULATION COMPRISING ANTI-CLAUDIN18.2 ANTIBODY"

GENEVA, June 30 -- SUZHOU TRANSCENTA THERAPEUTICS CO., LTD. (B6-501, Biobay 218 Xinghu Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123), TRANSCENTA HOLDING LIMITED (190 Elgin Avenue, George Town, Grand Cayman KY1-9008), TRANSCENTA THERAPEUTICS, INC. (Three Independence Way, Suite 114, Princeton, NJ 08540) filed a patent application (PCT/CN2024/140295) for "FORMULATION COMPRISING ANTI-CLAUDIN18.2 ANTIBODY" on Dec 18, 2024. With publication no. WO/2025/130921, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHANG, Fan ...